Letter to National Governors Association leaders and all governors stresses the importance of establishing certainty that flexibilities established early in the pandemic will be sustained.
Five faculty members from pharmacy schools and colleges nationwide have been selected to participate in the 18-month research mentorship program.
NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing.
Physicians’ letter recognizes community pharmacy as critical to improving patient access to care; congratulates NACDS Foundation on important work in addressing Latent Tuberculosis Infection Treatment.
The NACDS Board of Directors on July 8 held a “virtual” meeting with Department of Health and Human Services Assistant Secretary for Health ADM Brett P. Giroir, M.D.
NACDS, national pharmacy groups request clarity from HHS surrounding pharmacists’ vaccination authority under the PREP Act.
NACDS is urging the DEA to make electronic prescriptions for controlled substances (EPCS) mandatory.
Boutte brings to this critical role a 20-year career including chain pharmacy practice and key roles in government, at a health plan, and at NACDS.
On June 24, the NACDS Board of Directors “virtually” met with eight key members of the Administration and Congress.
FMI, NACDS, NCPA, NGA, and PCMA today issued the following joint statement outlining the best practices for pharmacies and PBMs to follow for documenting signature-free delivery or pick-up of prescription drugs during the Public Health Emergency related to the COVID-19 pandemic.
